Comparative and Combined Effects of Flaxseed and Olive Oils on Metabolic Dysfunction-Associated Fatty Liver Disease
Clinical Nutrition Open Science · 2026-11 · 100758
DOI: 10.1016/j.nutos.2026.100758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nutrition Open Science, 2026-11. Verfasst von Bushra Hashmi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated fatty liver disease (MAFLD) is strongly associated with dyslipidemia, obesity, and insulin resistance. Flaxseed and olive oils, rich in bioactive substances, may improve metabolic and hepatic function.
Objective
To determine whether supplementation with flaxseed oil, extra virgin olive oil, or their combination, compared with control, improves hepatic and metabolic outcomes and circulating cytokeratin-18 (CK-18) in patients with metabolic dysfunction-associated fatty liver disease (MAFLD).
Methods
A 16-week, randomized controlled experiment involved 112 MAFLD patients. Equal numbers of participants (n = 28 per group) were randomly assigned to a control (T0), flaxseed oil (T1), extra virgin olive oil (T2), or combined group (T3). They received their intervention for 16 th weeks. The baseline and post-intervention CK-18 levels, BMI, HbA1c, liver enzymes, lipid profile, and anthropometric and biochemical parameters were also measured. The post-intervention value of each outcome was the dependent variable, the treatment group was the fixed factor, and the baseline value was the covariate for analysis of covariance (ANCOVA) to compare groups. Statistical significance was set at p < 0.05.
Results
The combined flaxseed and extra virgin olive oil group (T3) showed the most favorable changes in the measured metabolic and biochemical outcomes compared with the control group. Compared with the control group, T3 demonstrated significantly greater reductions in CK-18, total cholesterol, triglycerides, and liver enzymes (all p < .001); however, this finding represents a biochemical change in the lipid profile and should not be interpreted as evidence of long-term cardiovascular benefit.
Conclusion
Flaxseed oil, extra virgin olive oil, and their combination improved biochemical and anthropometric results in MAFLD patients. The combination intervention had the best metabolic profile. Further well-powered trials including imaging and validated hepatic steatosis and fibrosis assessments are needed.
Zitieren
APA
Hashmi, B., Noreen, S., & Aja, P. M. (2026). Comparative and Combined Effects of Flaxseed and Olive Oils on Metabolic Dysfunction-Associated Fatty Liver Disease. Clinical Nutrition Open Science, 100758. https://doi.org/10.1016/j.nutos.2026.100758
Vancouver
Hashmi B, Noreen S, Aja PM. Comparative and Combined Effects of Flaxseed and Olive Oils on Metabolic Dysfunction-Associated Fatty Liver Disease. Clinical Nutrition Open Science. 2026:100758. doi:10.1016/j.nutos.2026.100758
BibTeX
@article{Hashmi2026,
author = {Hashmi, Bushra and Noreen, Sana and Aja, Patrick Maduabuchi},
title = {Comparative and Combined Effects of Flaxseed and Olive Oils on Metabolic Dysfunction-Associated Fatty Liver Disease},
journal = {Clinical Nutrition Open Science},
year = {2026},
pages = {100758},
doi = {10.1016/j.nutos.2026.100758}
}
EUVIMED